Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Germany Cell & Gene Therapy Cold Chain Logistics Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Cold Chain Management Systems, Shipment and Storage Medium, Cryogenic Packout Kits Others {Shipment Containers, Reusable Boxes, etc.})
4.2.2. By Services Offered (Transportation, Storage, Packaging)
4.2.3. By Mode of Transportation (Air, Ground, Water)
4.2.4. By Holding Temperature Range (Cryogenic, Refrigerated, Ambient, Others {Deep Freezers, Dry Ice, etc.})
4.2.5. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
4.2.6. By Company (2022)
4.2.7. By Region
4.3. Market Map
4.3.1. By Component
4.3.2. By Services Offered
4.3.3. By Mode of Transportation
4.3.4. By Holding Temperature Range
4.3.5. By End User
4.3.6. By Region
5. Western Germany Cell & Gene Therapy Cold Chain Logistics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component
5.2.2. By Services Offered
5.2.3. By Mode of Transportation
5.2.4. By Holding Temperature Range
5.2.5. By End User
6. Central Germany Cell & Gene Therapy Cold Chain Logistics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2. By Services Offered
6.2.3. By Mode of Transportation
6.2.4. By Holding Temperature Range
6.2.5. By End User
7. Eastern Germany Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Services Offered
7.2.3. By Mode of Transportation
7.2.4. By Holding Temperature Range
7.2.5. By End User
8. Rest of Germany Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Services Offered
8.2.3. By Mode of Transportation
8.2.4. By Holding Temperature Range
8.2.5. By End User
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
10.1. Recent Developments
10.2. Product Launches
10.3. Mergers & Acquisitions
11. Germany Cell & Gene Therapy Cold Chain Logistics Market: SWOT Analysis
12. Porter’s Five Forces Analysis
12.1. Competition in the Industry
12.2. Potential of New Entrants
12.3. Power of Suppliers
12.4. Power of Customers
12.5. Threat of Substitute Product
13. Competitive Landscape
13.1. AmerisourceBergen Corporation (World Courier)
13.1.1. Business Overview
13.1.2. Company Snapshot
13.1.3. Products & Services
13.1.4. Current Capacity Analysis
13.1.5. Financials (In case of listed)
13.1.6. Recent Developments
13.1.7. SWOT Analysis
13.2. United Parcel Service (Marken)
13.3. Catalent, Inc.
13.4. BioLife Solutions, Inc.
13.5. Cryoport, Inc.
13.6. Atelerix Ltd.
13.7. Biostor Ltd.
13.8. Thermo Fisher Scientific Inc.
13.9. Life Science Group Ltd (LSG)
13.10. Yourway Biopharma Services Company
14. Strategic Recommendations
15. About Us & Disclaimer